165 related articles for article (PubMed ID: 12818697)
61. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
Laorden ML; Fuertes G; González-Cuello A; Milanés MV
J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
[TBL] [Abstract][Full Text] [Related]
62. Effects of mepyramine and famotidine on the physostigmine-induced antinociception in the formalin test in rats.
Mojtahedin A; Tamaddonfard E; Zanbouri A
Pak J Biol Sci; 2008 Nov; 11(22):2573-8. PubMed ID: 19260335
[TBL] [Abstract][Full Text] [Related]
63. Effect of oral yohimbine on withdrawal jumping behaviour of morphine-dependent mice.
Iglesias V; Alamo C; Cuenca E; Morales L; Perez-Garcia C; Alguacil LF
Addict Biol; 1998 Oct; 3(4):459-63. PubMed ID: 26735121
[TBL] [Abstract][Full Text] [Related]
64. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
[TBL] [Abstract][Full Text] [Related]
65. Histamine H2 receptors mediate morphine-induced locomotor hyperactivity of the C57BL/6J mouse.
Mickley GA
Behav Neurosci; 1986 Feb; 100(1):79-84. PubMed ID: 3954883
[TBL] [Abstract][Full Text] [Related]
66. Involvement of central histaminergic and cholinergic systems in the morphine-induced increase in blood-brain barrier permeability to sodium fluorescein in mice.
Oishi R; Baba M; Nishibori M; Itoh Y; Saeki K
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):159-65. PubMed ID: 2566923
[TBL] [Abstract][Full Text] [Related]
67. Effects of aqueous, methanolic and chloroform extracts of rhizome and aerial parts of Valeriana officinalis L. on naloxone-induced jumping in morphine-dependent mice.
Sharifzadeh M; Hadjiakhoondi A; Khanavi M; Susanabadi M
Addict Biol; 2006 Jun; 11(2):145-51. PubMed ID: 16800827
[TBL] [Abstract][Full Text] [Related]
68. Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs.
Ritzmann RF
Pharmacol Biochem Behav; 1981 Apr; 14(4):575-7. PubMed ID: 7195040
[TBL] [Abstract][Full Text] [Related]
69. [The potential antinarcotic effects of guanfacine].
Marusov IV; Bogdanov EG; Marusova IB
Eksp Klin Farmakol; 1996; 59(3):24-7. PubMed ID: 8974578
[TBL] [Abstract][Full Text] [Related]
70. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
71. The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis.
Jovanović-Mićić D; Samardzić R; Beleslin DB
Eur J Pharmacol; 1995 Jan; 272(1):21-30. PubMed ID: 7713146
[TBL] [Abstract][Full Text] [Related]
72. Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists.
Hough LB; Nalwalk JW
Eur J Pharmacol; 1992 Apr; 215(1):69-74. PubMed ID: 1355443
[TBL] [Abstract][Full Text] [Related]
73. Repeated histamine pretreatment decreased amnesia induced by post-training administration of the drug in a step-down inhibitory avoidance test in mice.
Ahmadi S; Malekmohammadi N; Zarrindast MR
Arch Iran Med; 2010 May; 13(3):209-16. PubMed ID: 20433225
[TBL] [Abstract][Full Text] [Related]
74. A study of the H2-receptor for histamine stimulating adenylate cyclase in homogenates of guinea-pig lung parenchyma.
Foreman JC; Norris DB; Rising TJ; Webber SE
Br J Pharmacol; 1986 Jan; 87(1):37-44. PubMed ID: 2869813
[TBL] [Abstract][Full Text] [Related]
75. Effects of Papaver rhoeas extract on the expression and development of morphine-dependence in mice.
Pourmotabbed A; Rostamian B; Manouchehri G; Pirzadeh-Jahromi G; Sahraei H; Ghoshooni H; Zardooz H; Kamalnegad M
J Ethnopharmacol; 2004 Dec; 95(2-3):431-5. PubMed ID: 15507371
[TBL] [Abstract][Full Text] [Related]
76. Histamine in the locus coeruleus promotes descending noradrenergic inhibition of neuropathic hypersensitivity.
Wei H; Jin CY; Viisanen H; You HJ; Pertovaara A
Pharmacol Res; 2014 Dec; 90():58-66. PubMed ID: 25304183
[TBL] [Abstract][Full Text] [Related]
77. Role of withdrawal in reinstatement of morphine-conditioned place preference.
Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
[TBL] [Abstract][Full Text] [Related]
78. The antinociceptive effect of FR140423 in mice: involvement of spinal alpha(2)-adrenoceptors.
Ochi T; Goto T
Eur J Pharmacol; 2000 Jul; 400(2-3):199-203. PubMed ID: 10988334
[TBL] [Abstract][Full Text] [Related]
79. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
80. Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice.
Valeri P; Martinelli B; Pimpinella G; Severini C
Drug Alcohol Depend; 1989 Jan; 23(1):73-7. PubMed ID: 2920669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
